Biotech entity

B. Riley Financial

Company

pharma is the sole category represented across all 2 tracked stories. Wall Street Zen is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. At 5, the average consequence score sits below the same-window beat average of 5.5.

Last mentioned: Sep 5, 2026

Entity pulse

Recent coverage · B. Riley Financial

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about B. Riley Financial

pharma is the sole category represented across all 2 tracked stories. Wall Street Zen is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. At 5, the average consequence score sits below the same-window beat average of 5.5. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. We currently track 2 Biotech stories that mention B. Riley Financial, published between August 4, 2026 and August 8, 2026.

Stories tracked
2
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 32 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering B. Riley Financial. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning B. Riley Financial 2

B. Riley Financial is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.